BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van Varsseveld NC, Bisschop PHLT, Biermasz NR, Pereira AM, Fliers E, Drent ML. A long-term follow-up study of eighteen patients with thyrotrophin-secreting pituitary adenomas. Clin Endocrinol 2014;80:395-402. [DOI: 10.1111/cen.12290] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Sen HE, Ceylan EC, Atayev S, Sozen M, Bayrak BY, Cetinarslan B, Anik Y, Icli AD, Cabuk B, Anik I, Ceylan S. The Endoscopic Endonasal Transsphenoidal Approach for Thyrotropin-Secreting Pituitary Adenomas: Single-Center Experience and Clinical Outcomes of 49 Patients. World Neurosurg 2022;167:e1275-83. [PMID: 36096394 DOI: 10.1016/j.wneu.2022.09.027] [Reference Citation Analysis]
2 Zheng AC, Wang EJ, Aghi MK. Recent advancements in the molecular biology of pituitary adenomas. Expert Rev Endocrinol Metab 2022;:1-12. [PMID: 35702013 DOI: 10.1080/17446651.2022.2082942] [Reference Citation Analysis]
3 Yang Y, Liu J, Deng K, Lu L, Zhu H, Lian X, Bao X, Duan L, Yao Y. Clinical and Therapeutic Characteristics of Pituitary TSH-Secreting Adenoma in Adolescent-Onset Patients: Six Case Studies and Literature Review. Front Endocrinol (Lausanne) 2021;12:771673. [PMID: 35002961 DOI: 10.3389/fendo.2021.771673] [Reference Citation Analysis]
4 Peverelli E, Giardino E, Treppiedi D, Catalano R, Mangili F, Mantovani G. TSH-oma. Pituitary Adenomas 2022. [DOI: 10.1007/978-3-030-90475-3_8] [Reference Citation Analysis]
5 Greenman Y. Thyrotrophin-Secreting Pituitary Adenomas. The Pituitary 2022. [DOI: 10.1016/b978-0-323-99899-4.00012-3] [Reference Citation Analysis]
6 Strickland BA, Zada G. Pituitary Adenoma. Contemporary Skull Base Surgery 2022. [DOI: 10.1007/978-3-030-99321-4_19] [Reference Citation Analysis]
7 Agrawal N, Kim H, Wright K, Mehta S. Hormone Excess Syndromes of the Hypothalamic-Pituitary Axis. The Human Hypothalamus 2021. [DOI: 10.1007/978-3-030-62187-2_10] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Maione L, Li CY, Chanson P. Endocrinological diagnosis and treatment of TSH-secreting pituitary adenomas. Pituitary Tumors 2021. [DOI: 10.1016/b978-0-12-819949-7.00033-0] [Reference Citation Analysis]
9 Taguchi A, Kinoshita Y, Yamasaki F, Arita K, Tominaga A. Clinical characteristics and thyroid hormone dynamics of thyrotropin-secreting pituitary adenomas at a single institution. Endocrine 2021;73:151-9. [PMID: 33283257 DOI: 10.1007/s12020-020-02556-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Peto I, Abou-Al-Shaar H, White TG, Abunimer AM, Kwan K, Zavadskiy G, Wagner K, Black K, Eisenberg M, Bruni M, Dehdashti AR. Sources of residuals after endoscopic transsphenoidal surgery for large and giant pituitary adenomas. Acta Neurochir (Wien) 2020;162:2341-51. [PMID: 32700080 DOI: 10.1007/s00701-020-04497-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
11 Iglesias P, Magallón R, Mitjavila M, Rodríguez Berrocal V, Pian H, Díez JJ. Multimodal therapy in aggressive pituitary tumors. Endocrinología, Diabetes y Nutrición (English ed ) 2020;67:469-485. [DOI: 10.1016/j.endien.2020.08.011] [Reference Citation Analysis]
12 Gatto F, Arvigo M, Ferone D. Somatostatin receptor expression and patients' response to targeted medical treatment in pituitary tumors: evidences and controversies. J Endocrinol Invest 2020;43:1543-53. [PMID: 32557353 DOI: 10.1007/s40618-020-01335-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
13 Iglesias P, Magallón R, Mitjavila M, Rodríguez Berrocal V, Pian H, Díez JJ. Multimodal therapy in aggressive pituitary tumors. Endocrinol Diabetes Nutr (Engl Ed) 2020;67:469-85. [PMID: 31740190 DOI: 10.1016/j.endinu.2019.08.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
14 Căpraru OM, Gaillard C, Vasiljevic A, Lasolle H, Borson-Chazot F, Raverot V, Jouanneau E, Trouillas J, Raverot G. Diagnosis, pathology, and management of TSH-secreting pituitary tumors. A single-center retrospective study of 20 patients from 1981 to 2014. Ann Endocrinol (Paris) 2019;80:216-24. [PMID: 31400861 DOI: 10.1016/j.ando.2019.06.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Herguido NG, Fuentes ED, Venegas-Moreno E, Maorad LB, Flores-Martinez A, Ruiz PR, Dueñas MC, Roldán F, Fajardo E, Ruiz-Valdepeñas EC, Kaen A, Martín Schrader I, Cano DA, Soto-Moreno A. Surgical Outcome and Treatment of Thyrotropin-Secreting Pituitary Tumors in a Tertiary Referral Center. World Neurosurg 2019;130:e634-9. [PMID: 31276853 DOI: 10.1016/j.wneu.2019.06.180] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Beck-Peccoz P, Giavoli C, Lania A. A 2019 update on TSH-secreting pituitary adenomas. J Endocrinol Invest 2019;42:1401-6. [PMID: 31175617 DOI: 10.1007/s40618-019-01066-x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 8.8] [Reference Citation Analysis]
17 Cossu G, Daniel RT, Pierzchala K, Berhouma M, Pitteloud N, Lamine F, Colao A, Messerer M. Thyrotropin-secreting pituitary adenomas: a systematic review and meta-analysis of postoperative outcomes and management. Pituitary 2019;22:79-88. [PMID: 30390277 DOI: 10.1007/s11102-018-0921-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
18 Lania AGA, Betella N, Milani D. TSH-Secreting Pituitary Adenomas. Pituitary Disorders of Childhood 2019. [DOI: 10.1007/978-3-030-11339-1_8] [Reference Citation Analysis]
19 Iglesias P, Rodríguez Berrocal V, Díez JJ. Giant pituitary adenoma: histological types, clinical features and therapeutic approaches. Endocrine 2018;61:407-21. [DOI: 10.1007/s12020-018-1645-x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 35] [Article Influence: 10.2] [Reference Citation Analysis]
20 Beck-peccoz P, Giavoli C, Rodari G, Lania A. Physiopathology, Diagnosis and Treatment of Secondary Hyperthyroidism. Endocrinology 2018. [DOI: 10.1007/978-3-319-38681-2_8-1] [Reference Citation Analysis]
21 Beck-peccoz P, Giavoli C, Rodari G, Lania A. Physiopathology, Diagnosis, and Treatment of Secondary Hyperthyroidism. Endocrinology 2018. [DOI: 10.1007/978-3-319-44444-4_8] [Reference Citation Analysis]
22 Dichtel LE. A Rare Entity: TSH-Secreting Adenoma. Pituitary Tumors 2018. [DOI: 10.1007/978-3-319-90909-7_9] [Reference Citation Analysis]
23 Nazato DM, Abucham J. Diagnosis and treatment of TSH-secreting adenomas: review of a longtime experience in a reference center. J Endocrinol Invest 2018;41:447-54. [PMID: 29022276 DOI: 10.1007/s40618-017-0770-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
24 Yang C, Wu H, Wang J, Hu M, Xing X, Bao X, Wang R. Successful management of octreotide-insensitive thyrotropin-secreting pituitary adenoma with bromocriptine and surgery: A case report and literature review. Medicine (Baltimore) 2017;96:e8017. [PMID: 28885368 DOI: 10.1097/MD.0000000000008017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
25 Ibáñez-Costa A, Korbonits M. AIP and the somatostatin system in pituitary tumours. J Endocrinol 2017;235:R101-16. [PMID: 28835453 DOI: 10.1530/JOE-17-0254] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
26 van Eersel MEA, Meeuwisse-Pasterkamp SH, Muller Kobold AC, Meiners LC, den Dunnen WF, Hofland LJ, van den Berg G. Treatment of a thyrotropin-secreting pituitary adenoma (TSH-oma) with pasireotide LAR. Clin Endocrinol (Oxf) 2017;87:877-9. [PMID: 28741655 DOI: 10.1111/cen.13431] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
27 Fang HJ, Fu Y, Wu HW, Sun YL, Li YF, Zhang YZ, Zhong LY. Short-term Preoperative Octreotide for Thyrotropin-secreting Pituitary Adenoma. Chin Med J (Engl) 2017;130:936-42. [PMID: 28397723 DOI: 10.4103/0366-6999.204098] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
28 Rotermund R, Riedel N, Burkhardt T, Matschke J, Schmidt NO, Aberle J, Flitsch J. Surgical treatment and outcome of TSH-producing pituitary adenomas. Acta Neurochir (Wien) 2017;159:1219-26. [PMID: 28204898 DOI: 10.1007/s00701-017-3105-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
29 Tjörnstrand A, Nyström HF. DIAGNOSIS OF ENDOCRINE DISEASE: Diagnostic approach to TSH-producing pituitary adenoma. Eur J Endocrinol 2017;177:R183-97. [PMID: 28566440 DOI: 10.1530/EJE-16-1029] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 6.0] [Reference Citation Analysis]
30 Sapkota S, Horiguchi K, Tosaka M, Yamada S, Yamada M. Whole-Exome Sequencing Study of Thyrotropin-Secreting Pituitary Adenomas. J Clin Endocrinol Metab 2017;102:566-75. [PMID: 27854551 DOI: 10.1210/jc.2016-2261] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 5.2] [Reference Citation Analysis]
31 Greenman Y. Thyrotrophin-Secreting Pituitary Tumors. The Pituitary 2017. [DOI: 10.1016/b978-0-12-804169-7.00018-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
32 Mazerkina N, Trunin Y, Gorelyshev S, Golanov A, Kadashev B, Shishkina L, Rotin D, Karmanov M, Orlova E. Thyrotropin-secreting pituitary adenoma in an 11-year-old boy with type 1 autoimmune polyglandular syndrome. J Pediatr Endocrinol Metab 2016;29:237-40. [PMID: 26244671 DOI: 10.1515/jpem-2015-0018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
33 Amlashi FG, Tritos NA. Thyrotropin-secreting pituitary adenomas: epidemiology, diagnosis, and management. Endocrine 2016;52:427-40. [DOI: 10.1007/s12020-016-0863-3] [Cited by in Crossref: 54] [Cited by in F6Publishing: 39] [Article Influence: 7.7] [Reference Citation Analysis]
34 Mouslech Z, Somali M, Sakali AK, Savopoulos C, Mastorakos G, Hatzitolios AI. TSH-secreting pituitary adenomas treated by gamma knife radiosurgery: our case experience and a review of the literature. Hormones 2016;15:122-8. [DOI: 10.1007/bf03401412] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
35 Rimareix F, Grunenwald S, Vezzosi D, Rivière L, Bennet A, Caron P. Primary Medical Treatment of Thyrotropin–Secreting Pituitary Adenomas by First-Generation Somatostatin Analogs: A Case Study of Seven Patients. Thyroid 2015;25:877-82. [DOI: 10.1089/thy.2015.0041] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
36 Jouanneau E, Raverot G, Trouillas J, Brassier G. Adenomi ipofisari. EMC - Neurologia 2015;15:1-10. [DOI: 10.1016/s1634-7072(15)72180-x] [Reference Citation Analysis]
37 Wallace IR, Healy E, Cooke RS, Ellis PK, Harper R, Hunter SJ. TSH-secreting pituitary adenoma: benefits of pre-operative octreotide. Endocrinol Diabetes Metab Case Rep 2015;2015:150007. [PMID: 26113979 DOI: 10.1530/EDM-15-0007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
38 Cuny T, Barlier A, Feelders R, Weryha G, Hofland LJ, Ferone D, Gatto F. Medical therapies in pituitary adenomas: Current rationale for the use and future perspectives. Annales d'Endocrinologie 2015;76:43-58. [DOI: 10.1016/j.ando.2014.10.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
39 Yamada S, Fukuhara N, Horiguchi K, Yamaguchi-Okada M, Nishioka H, Takeshita A, Takeuchi Y, Ito J, Inoshita N. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases. J Neurosurg 2014;121:1462-73. [PMID: 25237847 DOI: 10.3171/2014.7.JNS1471] [Cited by in Crossref: 78] [Cited by in F6Publishing: 81] [Article Influence: 8.7] [Reference Citation Analysis]
40 Malchiodi E, Profka E, Ferrante E, Sala E, Verrua E, Campi I, Lania AG, Arosio M, Locatelli M, Mortini P, Losa M, Motti E, Beck-Peccoz P, Spada A, Mantovani G. Thyrotropin-secreting pituitary adenomas: outcome of pituitary surgery and irradiation. J Clin Endocrinol Metab 2014;99:2069-76. [PMID: 24552222 DOI: 10.1210/jc.2013-4376] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 6.8] [Reference Citation Analysis]